Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment

QR Code

Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment

Jesse Lopes da Silva,1 Fabiana Resende Rodrigues,2 Guilherme Gomes de Mesquita,2 Priscila Valverde Fernandes,2 Luiz Claudio Santos Thuler,1 Andreia Cristina de Melo1 1Division of Clinical Research and Technological Development, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil; 2Pat...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	da Silva JL, Rodrigues FR, de Mesquita GG, Fernandes PV, Thuler LCS, de Melo AC
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2021
Sujets:	triple-negative breast cancer neoadjuvant chemotherapy biomarkers residual burden cancer lymph node ratio. Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/7b85aab3ffc34272b6e335765ecc09ed
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Prognostic Influence of Residual Tumor-Infiltrating Lymphocyte Subtype After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
par: Jesse Lopes da Silva, et autres
Publié: (2021)

A Combined Nomogram Model to Predict Disease-free Survival in Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
par: Bingqing Xia, et autres
Publié: (2021)

Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triple-negative breast cancer: a systematic review and meta-analysis
par: Yuanfang Xin, et autres
Publié: (2021)

Prognostic Value of the Distribution of Lymph Node Metastasis in Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy
par: Bin Chen, et autres
Publié: (2021)

Efficacy and Safety of Adding Immune Checkpoint Inhibitors to Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials
par: Yunhai Li, et autres
Publié: (2021)

Lateral Pelvic Lymph Node Dissection for low locally advanced rectal cancer: a review
par: JU YONG CHEONG, et autres
Publié: (2020)

Radiation boost for synchronous solitary inguinal lymph node metastasis during neoadjuvant chemoradiotherapy for locally advanced rectal cancer
par: Mo Chen, et autres
Publié: (2021)

Outcomes of neoadjuvant chemotherapy in resectable, borderline resectable and locally advanced pancreatic cancer
par: Kamil D. Dalgatov, et autres
Publié: (2021)

Neoadjuvant therapy strategies for advanced gastric cancer: Current innovations and future challenges
par: Zhi Zhu, et autres
Publié: (2020)

The Clinical Value of Chemotherapy Combined With Capecitabine in Triple-Negative Breast Cancer—A Meta-Analysis
par: Zilin Zhang, et autres
Publié: (2021)

Assessing Clinicopathological Features and Prognosis of Triple-Negative Breast Cancer Patients: A Single-Center Study in Turkey
par: Saliha Karagöz Eren, et autres
Publié: (2021)

Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
par: Hyder T, et autres
Publié: (2021)

Mirna21 Expression in the Breast Cancer Tumor Tissue is Independent of Neoadjuvant Chemotherapy
par: Sales ACV, et autres
Publié: (2020)

Lymph Node Status in Colorectal Cancer; Is There a Case for Auditing the Pathologist and the Surgeon?
par: Emil Salmo, et autres
Publié: (2019)

Mechanisms behind prometastatic changes induced by neoadjuvant chemotherapy in the breast cancer microenvironment
par: Perelmuter VM, et autres
Publié: (2019)

Decrease in Blood Neutrophil-to-Lymphocyte Ratio Indicates Better Survival After Neoadjuvant Chemotherapy in Patients With Advanced Gastric Cancer
par: Ziyi Liu, et autres
Publié: (2021)

Prognostic and clinicopathological values of tissue expression of MFAP5 and ITM2A in triple-negative breast cancer: an immunohistochemical study
par: Abdulwahab Abuderman, et autres
Publié: (2020)

Novel therapeutic strategies for patients with metastatic triple-negative breast cancer
par: Inna P. Ganshina, et autres
Publié: (2021)

Characteristics and Risk Factors of Postoperative Complications in Gastric Cancer Patients Treated with Neoadjuvant Chemotherapy
par: SUN Chongyuan, et autres
Publié: (2021)

Modern view on the issues of diagnosis and verification of axillary lymph nodes involvement in early breast cancer
par: Irina V. Kolyadina, et autres
Publié: (2020)

Molecular Biomarkers Predict Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer Patients: Review
par: Ana Julia Aguiar de Freitas, et autres
Publié: (2021)

Pathological Complete Response with Neoadjuvant Trastuzumab Combined with Chemotherapy in HER2 Positive Breast Cancer: A Single Institution Retrospective Analysis from Vietnam
par: Phung HT, et autres
Publié: (2020)

Value of 18F-FDG PET/CT for predicting axillary pathologic complete response following neoadjuvant systemic therapy in breast cancer patients: emphasis on breast cancer subtype
par: Cornelis M. de Mooij, et autres
Publié: (2021)

Laparoscopic radical prostatectomy and extended pelvic lymph node dissection: a combined technique
par: Piotr Jarzemski, et autres
Publié: (2020)

Lymphatic Drainage of the Breast: from Theory to Surgical Practice
par: Fregnani,José Humberto Tavares Guerreiro, et autres
Publié: (2009)

A Comparison of Different Schemes of Neoadjuvant Chemotherapy Followed by Concurrent Chemotherapy and Radiotherapy for Locally Advanced Cervical Cancer: A Retrospective Study
par: Tian X, et autres
Publié: (2021)

Lymph node ratio as a predictor for minor salivary gland cancer in head and neck
par: Hidenori Suzuki, et autres
Publié: (2021)

Influence of correction of nutritive deficiency on the effectiveness of neoadjuvant chemotherapy in patients with locally advanced gastric cancer
par: Nadezhda A. Brish, et autres
Publié: (2021)

Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in Advanced Breast Cancer by Ultrasound and Clinicopathological Features Using a Nomogram
par: Hao Cui, et autres
Publié: (2021)

The Influence of Lymph Node Count on Oncological Outcome of Radical Cystectomy in Chemotherapy Pre-Treated and Chemotherapy-Naïve Patients with Muscle Invasive Bladder Cancer
par: Artur Lemiński, et autres
Publié: (2021)

Metastatic Lymph Node Ratio for Predicting Recurrence in Medullary Thyroid Cancer
par: Jinyoung Kim, et autres
Publié: (2021)

Duration of Perioperative Chemotherapy in Locally Advanced Gastric Cancer: A “Less Is More” Question When ypN0 Is Achieved
par: Zining Liu, et autres
Publié: (2021)

The value of multidetector-row computed tomography in lymph node staging of gastric cancer: a preliminary Vietnamese study
par: Nguyen Van Sang, et autres
Publié: (2020)

Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer
par: Shen,Xiaogang, et autres
Publié: (2017)

Machine Learning-Based Radiomics Nomogram With Dynamic Contrast-Enhanced MRI of the Osteosarcoma for Evaluation of Efficacy of Neoadjuvant Chemotherapy
par: Lu Zhang, et autres
Publié: (2021)

Triple-negative breast cancer: treatment challenges and solutions
par: Collignon J, et autres
Publié: (2016)

Association of tumor‐infiltrating lymphocytes before and after neoadjuvant chemotherapy with pathological complete response and prognosis in patients with breast cancer
par: Jin Hong, et autres
Publié: (2021)

Current advances in biomarkers for targeted therapy in triple-negative breast cancer
par: Fleisher B, et autres
Publié: (2016)

Real-World Data from a Refractory Triple-Negative Breast Cancer Cohort Selected Using a Clinical Data Warehouse Approach
par: Hana Kim, et autres
Publié: (2021)

Establishment and validation of an individualized macrophage-related gene signature to predict overall survival in patients with triple negative breast cancer
par: Peng Su, et autres
Publié: (2021)